A Phase II, Open-lable, Single Center Study to Evaluate the Efficacy and Safety of Palbociclib for the Treatment of Retinoblastoma Protein-Expressing Germ Cell Tumors.
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2016
At a glance
- Drugs Palbociclib (Primary)
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 02 Dec 2015 New trial record